ASXL2 mutation is recurrent in non-de novo AML1-ETO-negative acute myeloid leukemia

被引：0
|
作者：
Xiang Zhang
Jie Jin
Wenjuan Yu
机构：
[1] Zhejiang University College of Medicine,Department of Hematology, The First Affiliated Hospital
[2] Zhejiang University,Institute of Hematology
[3] Key Laboratory of Hematologic Malignancies,undefined
[4] Diagnosis and Treatment,undefined
[5] Zhejiang,undefined
来源：
Annals of Hematology | 2019年 / 98卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2621 / 2623
页数：2
相关论文
共 50 条
  • [31] Molecular pathogenesis of AML (Mouse models of acute myeloid leukemia with AML1-ETO fusion proteins)
    Zhang, DE
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 76 (Suppl 1) : 249 - 249
  • [32] Prognostic significance of FLT3/ITD mutation in AML1/ETO-associated acute myeloid leukemia
    Kim, Yeo-Kyeoung
    Kim, Hee-Nam
    Lee, Il-Kwon
    Bang, Soo-Mee
    Jo, Deog-Yeon
    Won, Jong-Ho
    Yim, Chang-Yeol
    Yang, Deok-Hwan
    Lee, Je-Jung
    Kim, Hyeoung-Joon
    BLOOD, 2007, 110 (11) : 1023A - 1023A
  • [33] Prognostic significance of FLT3/ITD mutation in patients with AML1/ETO associated acute myeloid leukemia
    Kim, Y.-K.
    Kim, H. N.
    Lee, I. K.
    Jo, D. Y.
    Won, J. H.
    Choi, J. H.
    Lee, S. R.
    Shim, H. J.
    Ahn, J. S.
    Yang, D. H.
    Lee, J. J.
    Park, H. S.
    Kim, H. J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 21 - 21
  • [34] AML1 mutation and its coexistence with different transcription factor gene families in de novo acute myeloid leukemia: redundancy or synergism
    Auewarakul, Chirayu U.
    Leecharendkeat, Amporn
    Tocharoentanaphol, Chintana
    Promsuwicha, Orathai
    Sritana, Narongrit
    Thongnoppakhun, Wanna
    HAEMATOLOGICA, 2007, 92 (06) : 861 - 862
  • [35] Quantification of AML1-ETO fusion transcript as a prognostic indicator in acute myeloid leukemia
    Yoo, Soo Jin
    Chi, Hyun Sook
    Jang, Seongsoo
    Seo, Eul-Ju
    Seo, Jong Jin
    Lee, Je-Hwan
    Park, Hyo-Soon
    Park, Chan Jeoung
    HAEMATOLOGICA, 2005, 90 (11) : 1493 - 1501
  • [36] Simultaneous PML/RARα and AML 1/ETO gene rearrangements in a patient with acute myeloid leukemia
    N Stavroyianni
    T Kalmantis
    X Yataganas
    Leukemia, 1999, 13 (8) : 1294 - 1295
  • [37] Potential Therapeutic Approaches for the Treatment of Acute Myeloid Leukemia with AML1-ETO Translocation
    Arora, Rashi
    Sawney, Sharad
    Saluja, Daman
    CURRENT CANCER DRUG TARGETS, 2016, 16 (03) : 215 - 225
  • [38] A Case of AML1/ETO Positive Child with Acute Myeloid Leukemia with Poor Prognosis
    Zhang, Xiaofang
    Wu, Yiping
    Wang, Lihua
    Li, Haixin
    Li, Ruimin
    CLINICAL LABORATORY, 2023, 69 (02) : 410 - 413
  • [39] De Novo Acute Myeloid Leukemia (AML) with RUNX1 Mutations Shows Characteristic Clinicopathologic Features
    Quesada, Andres
    Luthra, Rajyalakshmi
    Patel, Keyur P.
    Singh, Rajesh
    Routbort, Mark
    Loghavi, Sanam
    Khoury, Joseph D.
    Medeiros, Jeffrey
    Bueso-Ramos, Carlos E.
    Kanagal-Shamanna, Rashmi
    MODERN PATHOLOGY, 2016, 29 : 371A - 371A
  • [40] Distinct Mutation Landscapes Between Acute Myeloid Leukemia With Myelodysplasia-Related Changes and De Novo Acute Myeloid Leukemia
    Gao, Yajuan
    Jia, Mingnan
    Mao, Yueying
    Cai, Hao
    Jiang, Xianyong
    Cao, Xinxin
    Zhou, Daobin
    Li, Jian
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2022, 157 (05) : 691 - 700
12345